Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Prostate Cancer Therapies Raise Heart Risk

But Study Shows Some Anti-Hormone Treatments Are Less Risky Than Others
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 23, 2009 (Berlin) -- The anti-hormone therapies used to treat prostate cancer can raise the risk of heart disease, but some drugs appear to be safer for the heart than others, researchers report.

The study, the largest to date to look at the issue, suggests that overall, anti-hormone therapies were associated with about a 25% increased risk of heart disease.

But in a more detailed analysis by type of hormone therapy, agents known as gonadotropin-releasing hormone agonists proved more risky than anti-androgen drugs, says Mieke Van Hemelrijck, a PhD candidate in cancer epidemiology at King's College in London.

The results were presented at a joint meeting of the European Cancer Organization and the European Society of Medical Oncology (ESMO).

Anti-Hormone Treatments for Prostate Cancer

Prostate cancer is the most common type of cancer in men, accounting for about one in four of all new cancer cases diagnosed in men each year, Van Hemelrijck tells WebMD.

Prostate tumors "grow in an environment of [the hormone] testosterone, so a common treatment is to block testosterone, either by interrupting its production or by making sure testosterone can't get into the prostate," she says.

That can be achieved in one of three ways. Some men undergo surgical removal of the testicles to eliminate the body's main source of testosterone production.

Others receive injections of gonadotropin-releasing hormone agonists. They actually block testosterone production by the testicles, so there is almost no circulating testosterone in the body, Van Hemelrijck says. Examples include Lupron, Viadur, Eligard, Zoladex, Trelstar, and Vantas.

Anti-androgen pills, on the other hand, block testosterone from attaching to prostate cells. "This means there is still testosterone in the body; it just can't get to the prostate," she says. These include Eulexin, Casodex, and Nilandron.

Measuring Risk of Prostate Cancer Treatments

The new study involved more than 30,000 men in Sweden with advanced prostate cancer who received anti-hormone treatments between 1997 and 2006. The researchers compared their rates of heart problems to those in the general Swedish population.

Most of the patients received one treatment, but 38% received both gonadotropin-releasing hormone agonists and anti-androgen pills. The men were followed for about three years.

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D